Fermenta Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 569.08 million compared to INR 980.28 million a year ago. Revenue was INR 588.04 million compared to INR 1,007.18 million a year ago. Net loss was INR 278 million compared to INR 80.9 million a year ago. Basic loss per share from continuing operations was INR 9.63 compared to INR 2.8 a year ago. Diluted loss per share from continuing operations was INR 9.63 compared to INR 2.8 a year ago.
For the six months, sales was INR 1,393.56 million compared to INR 1,899.17 million a year ago. Revenue was INR 1,432.59 million compared to INR 1,964.51 million a year ago. Net loss was INR 259.68 million compared to INR 104.33 million a year ago. Basic loss per share from continuing operations was INR 8.99 compared to INR 3.62 a year ago. Diluted loss per share from continuing operations was INR 8.99 compared to INR 3.62 a year ago.